Actio Biosciences, Inc.

Actio Biosciences, Inc. company information, Employees & Contact Information

We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.

Company Details

Employees
40
Founded
-
Address
11202 El Camino Real, San Diego,ca 92130,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
jobs.
HQ
San Diego, CA
Looking for a particular Actio Biosciences, Inc. employee's phone or email?

Actio Biosciences, Inc. Questions

News

Actio Advancing Genetics-Driven Pipeline - San Diego Business Journal

Actio Advancing Genetics-Driven Pipeline San Diego Business Journal

Actio Biosciences to Participate in Evercore Emerging Private Biotech Conference - Business Wire

Actio Biosciences to Participate in Evercore Emerging Private Biotech Conference Business Wire

Actio Biosciences to Participate in Piper Sandler Spring Biopharma Symposium - BioSpace

Actio Biosciences to Participate in Piper Sandler Spring Biopharma Symposium BioSpace

Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy - Yahoo Finance

Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy Yahoo Finance

Actio Biosciences to Participate in Upcoming Investor Conferences - BioSpace

Actio Biosciences to Participate in Upcoming Investor Conferences BioSpace

Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer - Yahoo Finance

Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer Yahoo Finance

Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases - Business Wire

Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases Business Wire

Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases - Business Wire

Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases Business Wire

Actio Biosciences Receives Orphan Drug and Rare Pediatric Disease Designations for ABS-0871 for the Treatment of Charcot-Marie-Tooth Disease 2C - Business Wire

Actio Biosciences Receives Orphan Drug and Rare Pediatric Disease Designations for ABS-0871 for the Treatment of Charcot-Marie-Tooth Disease 2C Business Wire

Top Actio Biosciences, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant